bioMérieux (BMXMF) Stock Forecast & Price Target

$107.75

0.00 (0.00%)

(As of 11/4/2024 ET)

bioMérieux - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy

Based on 1 Analyst Ratings

Sell
0

Hold
0

Buy
1

Based on 1 Wall Street analysts who have issued ratings for bioMérieux in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 1 analysts, 1 has given a strong buy rating for BMXMF.

Consensus Price Target

N/A

BMXMF Analyst Ratings Over Time

Type	Current Forecast 11/6/23 to 11/5/24	1 Month Ago 10/7/23 to 10/6/24	3 Months Ago 8/8/23 to 8/7/24	1 Year Ago 11/6/22 to 11/6/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Strong Buy	Strong Buy	Buy	Moderate Buy

Market "Famine" Coming (Ad)

Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...

For a limited time, he's revealing his latest forecast here.

BMXMF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BMXMF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

bioMérieux Stock vs. The Competition

Type	bioMérieux	Medical Companies	S&P 500
Consensus Rating Score	4.00	2.79	2.50
Consensus Rating	Strong Buy	Moderate Buy	Hold
Predicted Upside	N/A	16,384.14% Upside	10.48% Upside
News Sentiment Rating	Positive News See Recent BMXMF News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target
8/22/2024	UBS Group 4 of 5 stars	K. Deshpande Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
9/29/2023	HSBC 2 of 5 stars		Upgrade	Hold ➝ Buy
12/21/2022	Societe Generale 2 of 5 stars		Upgrade	Hold ➝ Buy
12/16/2022	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	€89.70 ➝ €92.50

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:44 AM ET.

BMXMF Forecast - Frequently Asked Questions

: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for bioMérieux in the last twelve months. There is currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" BMXMF shares.
: According to analysts, bioMérieux's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Over the previous 90 days, bioMérieux's stock had 1 upgrade by analysts.
: bioMérieux has been rated by research analysts at UBS Group in the past 90 days.
: Analysts like bioMérieux more than other "medical" companies. The consensus rating for bioMérieux is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BMXMF compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

The centerpiece of Trump’s crypto’s masterplan … (Ad)

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Click here to find out more about what could be Trump and JD Vance’s favorite coin.

This page (OTCMKTS:BMXMF) was last updated on 11/5/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

bioMérieux (BMXMF) Stock Forecast & Price Target